This report presents a cost-benefit analysis of increased spending on TB using impacts and costs drawn from the Global Plan to End Tuberculosis, 2023‒2030. It was authored by Madhukar Pai and colleagues.
This report presents a cost-benefit analysis of increased spending on TB using impacts and costs drawn from the Global Plan to End Tuberculosis, 2023‒2030. It was authored by Madhukar Pai and colleagues.